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Abstract
Stature is a classical and highly heritable complex trait, with 80%–90% of variation explained by genetic factors. In recent
years, genome-wide association studies (GWAS) have successfully identified many common additive variants influencing
human height; however, little attention has been given to the potential role of recessive genetic effects. Here, we
investigated genome-wide recessive effects by an analysis of inbreeding depression on adult height in over 35,000 people
from 21 different population samples. We found a highly significant inverse association between height and genome-wide
homozygosity, equivalent to a height reduction of up to 3 cm in the offspring of first cousins compared with the offspring
of unrelated individuals, an effect which remained after controlling for the effects of socio-economic status, an important
confounder (x2 = 83.89, df = 1; p= 5.2610220). There was, however, a high degree of heterogeneity among populations:
whereas the direction of the effect was consistent across most population samples, the effect size differed significantly
among populations. It is likely that this reflects true biological heterogeneity: whether or not an effect can be observed will
depend on both the variance in homozygosity in the population and the chance inheritance of individual recessive
genotypes. These results predict that multiple, rare, recessive variants influence human height. Although this exploratory
work focuses on height alone, the methodology developed is generally applicable to heritable quantitative traits (QT),
paving the way for an investigation into inbreeding effects, and therefore genetic architecture, on a range of QT of
biomedical importance.
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Introduction
Height is a classic complex trait, which is influenced by both
genetic and non-genetic factors. Observed increases in height in
developed countries over the last few generations suggest that
environmental factors such as nutrition and childhood healthcare
play an important role in determining adult height [1,2]. Within
any one population at one point in time, 80–90% of the variation
in height is explained by genetic factors [3,4,5,6,7,8]. These
characteristics, plus the fact that height is cheaply and accurately
measurable and has been assessed in many thousands of study
subjects, make it an attractive model for investigating the genetic
architecture of quantitative traits generally [9,10]. Height is not
merely of interest as a model quantitative trait (QT): a better
understanding of the genetic mechanisms influencing height offers
insights into genetic variants influencing growth and development
[11]. Because height is associated with a range of complex diseases,
including cancer, [12,13,14,15] and because pleiotropic effects
have been observed between disease-associated and height-
associated genetic variants [16,17,18], a better understanding of
the genetic mechanisms influencing height may also provide
biological insights into disease mechanisms.
In a seminal work published almost a century ago, Fisher first
proposed that the heritability of height results from the combined
effects of many genetic variants of individually small effect size
[19]. In recent years, the advent of genome-wide association
studies (GWAS) has enabled this theory to be tested empirically. A
GWAS of over 180,000 individuals conducted by the GIANT
Inbreeding Depression on Height
PLoS Genetics | www.plosgenetics.org 2 July 2012 | Volume 8 | Issue 7 | e1002655
(Genome-wide Investigation of Anthropometric Measures) con-
sortium found common genetic variants at more than 180 loci
influencing human height [20]. Despite the undoubted success of
GWAS, even this very large study discovered variants explaining
in total only around 10% of phenotypic variation [20]. This
‘‘missing heritability’’ [21] has become an important subject of
debate in genetic epidemiology because of the implications it has
for future gene discovery strategies and indirectly on attempts to
predict phenotype from genotype. Yang and colleagues proposed a
different approach to identifying this missing heritability [22].
Instead of using GWAS to identify individual genome-wide
significant SNPs associated with stature, they considered all SNPs
simultaneously, allowing the entire GWAS data to be used as
predictors. Using this approach, they explained up to 40% of the
variance in height. This still leaves ,40% of variance unexplained
by common genetic variants. The authors of the large GIANT
study cited above predict that increased GWAS sample sizes will
identify more common variants of moderate-to-small effect size
and will increase the proportion of heritable variation explained
merely to around 20% [20,22]). Therefore, alternative strategies
are required in order to detect rarer variants, structural variants,
variants of very small effect size, and interactions, including
dominance and epistasis [21].
This study explores whether there is evidence for genome-wide
recessive genetic effects, or inbreeding depression, on height.
Inbreeding depression implies directional dominance: i.e. that
dominance is on average in the same direction across loci. An
association between height and genome-wide homozygosity would
imply that height was influenced by the combined effects of many
recessive variants of individually small effect size, scattered across
the genome. On the face of it, this endeavour looks unpromising.
Most pedigree and GWAS studies investigating the genetic
architecture of height to date have found no strong evidence of
deviation from an additive genetic model [23]. Three heritability
studies have found little evidence for dominance variance
[24,25,26]. Absence of evidence for dominance variance need
not, however, be inconsistent with evidence of inbreeding
depression: it can be shown that, assuming a large number of
contributing loci, it is theoretically possible to have inbreeding
depression in the absence of detectable dominance variance [27].
Dominance variance may be difficult to estimate in study designs
where genome-wide additive and dominance coefficients are
highly correlated [26]. Independently of GWAS, epidemiologists
have long observed associations between parental relatedness and
reduced height [28,29,30,31], although not all studies have found
such an association [32,33]. A recent small study of the isolated
Norfolk Island population found an association between reduced
height and both parental relatedness (estimated from genealogical
data) and genome-wide homozygosity (estimated from microsat-
ellite markers) [34]. Finally, whilst many twin studies have
concluded that height is purely additive, an extended twin family
design using large numbers (n = 29,691) revealed a non-additive
genetic component of 9.4% which was balanced by extra additive
variance due to assortative mating (confounded with shared
environment in twin studies). As assortative mating increases the
correlation in dizygotic twins above half that in monozygotic
twins, whereas dominance does the opposite, they appear to cancel
each other out, so height looks perfectly additive from twins alone
[35].
The aim of this study was to explore the association between
genome-wide homozygosity and adult height, controlling for the
effects of potential confounding factors. The study involved over
35,000 subjects, drawn from 21 population samples. We invited
studies to participate in the consortium which we knew were
conducted in isolated populations, where both the mean and
variance in genome-wide homozygosity are higher. In this way, we
optimised our chances of being able to detect an effect, should one
exist. We found highly significant evidence of an inverse
association between genome-wide homozygosity and height, with
significant heterogeneity among sample sets.
Results
We explored the association between genome-wide homozy-
gosity and height in 21 European or European-heritage popula-
tions (Table 1). All samples were genotyped using the Illumina
platform (see Materials and Methods and Supporting Informa-
tion). Because different Illumina platforms were used by different
studies, we extracted the SNPs present in the Illumina HumanHap
300 panel (common to all the Illumina platforms used). The
number of SNPs remaining after quality control procedures had
been run on a population-by-population basis are given in Table 1,
as are details of the mean age and height of the samples and the
proportion of women in each sample.
We used three different measures of genome-wide homozygos-
ity. FROH is defined as the percentage of the typed autosomal
genome in runs of homozygosity (ROH) greater than or equal to
1.5 Mb in length. FROH is strongly correlated with the degree of
relatedness between an individual’s parents [36]. FROHLD is a
modification of FROH, derived using a panel of independent SNPs,
where all SNPs in strong linkage disequilibrium (LD) have been
removed. This is a more stringent estimate of parental relatedness:
removing SNPs that are in strong LD with other SNPs means that
all ROH detected are likely to be the result of recent parental
relatedness and not ancient patterns of shared ancestry. The third
measure we used was observed homozygosity (Fhom). This is
defined as the number of observed homozygous genotypes per
individual, expressed as a percentage of the number of non-
missing genotypes for that individual. This is a much less precise
estimate of parental relatedness, as Fhom is a single-point measure
which captures all genotyped homozygous loci, not just those
located in long ROH. Thus it reflects not only recent parental
relatedness but also more ancient aspects of population history,
such as population isolation and bottlenecks.
Author Summary
Studies investigating the extent to which genetics influ-
ences human characteristics such as height have concen-
trated mainly on common variants of genes, where having
one or two copies of a given variant influences the trait or
risk of disease. This study explores whether a different type
of genetic variant might also be important. We investigate
the role of recessive genetic variants, where two identical
copies of a variant are required to have an effect. By
measuring genome-wide homozygosity—the phenome-
non of inheriting two identical copies at a given point of
the genome—in 35,000 individuals from 21 European
populations, and by comparing this to individual height,
we found that the more homozygous the genome, the
shorter the individual. The offspring of first cousins (who
have increased homozygosity) were predicted to be up to
3 cm shorter on average than the offspring of unrelated
parents. Height is influenced by the combined effect of
many recessive variants dispersed across the genome. This
may also be true for other human characteristics and
diseases, opening up a new way to understand how
genetic variation influences our health.
Inbreeding Depression on Height
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Figure 1 shows the sample means, with 95% confidence
intervals, of these three measures of genome-wide homozygosity.
Whereas in general the three measures were strongly correlated,
differences were observed, particularly between FROHLD and Fhom.
For example, the Estonian sample (Estonian Genome Centre of
University of Tartu [EGCUT]) had the second highest mean value
for Fhom, but it had one of the lowest mean values for FROHLD. For
all three measures of genome-wide homozygosity there is a
continuum of values. The isolate populations are generally located
at the more homozygous end of the spectrum, but with
considerable variation amongst the different sample sets. For
example, there is almost a three-fold difference in mean FROHLD
between the Northern Sweden Population Health Study (NSPHS)
and ORCADES. The Finnish sample sets and some others (for
example, CROATIA-Split and EGCUT) have intermediate levels
of homozygosity, whilst the urban and national collections from
Scotland, the Netherlands and Australia are the least homozygous.
There was more than an order of magnitude difference in mean
FROHLD between the most and the least homozygous population
samples.
The purpose of the first part of the analysis was to explore the
association between height and homozygosity, as measured in
different ways. First, we estimated the association between height
and FROH, adjusting for age, sex and (in sample sets including
related individuals) genomic kinship (Table 2, Figure S1). We
found evidence for a small but strongly significant
(p= 1.23610211) inverse association between FROH and height.
This association was significant in nine of the twenty-one sample
sets in the study. In nine further sample sets, confidence intervals
overlapped with zero but the direction of the effect was consistent
with an inverse association between FROH and height. In none of
the sample sets was there a significant positive association between
FROH and height. An increase of 1% in FROH was associated with
a decrease of 0.012 (SE = 0.0018) in the z-score for height
(approximately 0.09 cm). Using pedigree and FROH data from
three separate population samples, we estimated that this is
equivalent to a reduction in height of 0.7 cm in the offspring of
first cousins, compared with the offspring of unrelated individuals
(based on FROH differences of 6.6, 7.4 and 7.4 in the offspring of
first cousins compared with the offspring of unrelated individuals
in the Micro-Isolates in South Tyrol (MICROS), ORCADES and
Irish data sets respectively – see Materials and Methods).
The second analysis estimated the association between height
and FROHLD, adjusted for age, sex and genomic kinship. Again,
there was evidence of a very strongly significant inverse association
(p= 1.40610288) between FROHLD and height (Table 2, Figure 2).
This association was significant in seven of the twenty-one sample
sets in this study. In eleven further sample sets, confidence intervals
overlapped with zero but the direction of the effect was consistent
with an inverse association between FROHLD and height. In none
Table 1. Sample details.
Study Location N (% female) Platform1
N SNPs
after QC
N SNPs in LD
pruned panel
Height (cm)
mean (SD)
Age (years)
mean (SD)
CROATIA-Korcˇula3 Dalmatian Island, Croatia 866 (64) 370 318,448 48,168 168.1 (9.2) 55.8 (13.7)
CROATIA-Split2 City of Split, Croatia 499 (43) 370 325,070 33,718 172.5 (9.5) 49.0 (14.7)
CROATIA-Vis3 Dalmatian Island, Croatia 778 (59) 300 299,337 47,802 167.8 (10.0) 56.5 (15.3)
EGCUT2 National collection, Estonia 2395 (52) 370 321,859 33,852 172.3 (9.7) 40.1 (16.2)
ERF3 Village in the Netherlands 789 (62) 300 307,909 43,019 165.0 (8.9) 51.1 (14.2)
FINRISK2 Finland 1884 (47) 610 300,312 45,433 169.9 (9.9) 55.7 (12.1)
HBCS4 Helsinki, Finland 1721 (57) 610 298,835 45,479 169.0 (8.8) 61.5 (2.9)
H20002 Finland 2101 (51) 610 300,493 45,159 169.6 (9.5) 50.7 (11.1)
INGI-CARL3 Village in Italy 430 (62) 370 300,235 48,204 159.8 (9.6) 50.4 (16.3)
INGI-FVG3 Villages in Italy 961 370 300,648 47,960 168.7 (9.3) 50.9 (15.6)
INGI-VB3 Villages in a valley in Italy 1661 (56) 370 305,451 48,217 164.7 (9.7) 54.7 (18.3)
LBC19214 Lothian Region, Scotland 512 (58) 610 297,795 46,827 163.2 (9.2) 79.1 (0.6)
LBC19364 Lothian Region, Scotland 1005 (49) 610 297,795 47,139 166.5 (8.9) 69.6 (0.8)
MICROS3 Villages in a valley in Italy 1079 (57) 300 307,473 47,118 166.2 (9.4) 45.2 (16.1)
NFBC19664 Northern Finland 4988 (52) 370 302,524 44,560 171.2 (9.2) 31.0 (0)
NSPHS3 Village in Northern Sweden 638 (53) 300 303,583 34,917 164.3 (9.6) 47.1 (20.7)
ORCADES3 Orkney Islands, Scotland 697 (54) 300 306,689 45,208 167.4 (9.4) 55.0 (15.4)
QIMR2 NW Europeans, Australia 3925 (58) 370, 610 295,000 31,760 169.2 (9.7) 39.7 (18.0)
RS2 Rotterdam, Netherlands 5737 (59) 300 307,042 49,162 166.9 (9.3) 69.0 (8.8)
SOCCS5 National collection, Scotland 842 (51) 300 306,310 46,781 169.2 (9.6) 50.7 (5.9)
YFS2 Finland 2437 (54) 670 299,112 44,890 172.2 (9.3) 37.7 (5.0)
1All data were analysed using Illumina SNP arrays. 300 refers to the Illumina HumanHap 300 panel, 370 to the Illumina HumanHap 370 Duo/Quad panels, 610 to the
Illumina Human 610 Quad panel and 670 to the Illumina Human 670 Quad panel. In order to harmonise the data, the analysis was conducted using only those SNPs
present in the HumanHap 300 panel.
2Population-based studies.
3Population-based studies in isolated populations.
4Birth cohort studies.
5Case control studies.
doi:10.1371/journal.pgen.1002655.t001
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of the sample sets was there a significant effect in the other
direction. A 1% increase in FROHLD was associated with a
decrease of 0.065 (SE = 0.0032) in the z-score for height
(approximately 0.6 cm). Again using pedigree and FROHLD data
from three separate population samples, this gave a much higher
estimate of a reduction in height of between 2.8 and 3.3 cm in the
offspring of first cousins compared with the offspring of unrelated
parents (based on FROHLD differences of 2.8, 3.3 and 2.9 in the
offspring of first cousins compared with the offspring of unrelated
individuals in the MICROS, ORCADES and Irish data sets
respectively).
The third analysis estimated the association between height and
Fhom, adjusting for age and sex (Figure S2). Again, there was
evidence of a very strongly significant inverse association between
Fhom and height (p= 1.10610
283). The direction of effect was
consistent for fourteen sample sets, significantly so for seven of
these, and not significantly different from zero but of opposite sign
in the final seven studies. A 1% increase in Fhom was associated
with a decrease of 0.11 (SE = 0.0057) in the z-score for height
(approximately 1 cm). Again using pedigree and Fhom data from
three separate population samples, this gave an estimate of a
reduction in height of between 2.7 and 3.3 cm in the offspring of
first cousins compared with the offspring of unrelated people,
identical to the estimate obtained using FROHLD (based on Fhom
differences of 2.7, 3.3 and 2.7 in the offspring of first cousins
compared with the offspring of unrelated individuals in the
MICROS, ORCADES and Irish data sets respectively).
We explored whether the signal observed in the Fhom analysis
was driven by homozygous genotypes located in long ROH, or
from the more common, homozygous genotypes resulting from the
chance inheritance of identical shorter haplotypes from both
parents. This analysis estimated the association between height
and Fhom, adjusted for age, sex and FROH. Again, a significant
association was observed, but both the magnitude and the
significance of the effect were reduced compared to the previous
analysis (Table 2), suggesting that most, but not all, of the signal
was coming from long ROH.
Figure 1. Three alternative measures of mean homozygosity,
with 95% confidence intervals, by population sample. (A) shows
mean FROH by population sample. FROH is defined as the percentage of
the genotyped autosomal genome in ROH measuring at least 1.5 Mb.
Mean values of FROH per population (with 95% confidence intervals) are:
CROATIA-Korcˇula = 1.27 (1.18, 1.36); CROATIA-Split = 0.65 (0.59, 0.71);
CROATIA-Vis = 0.94 (0.87,1.01); EGCUT = 0.56 (0.54, 0.58); ERF = 1.12
(1.04, 1.20); FINRISK = 0.79 (0.77, 0.82); HBCS = 0.63 (0.60, 0.65);
H2000 = 0.84 (0.82, 0.86); INGI-CARL = 0.78 (0.65, 0.91); INGI-FVG = 1.49
(1.40, 1.58); INGI-VB = 0.76 (0.71, 0.81); LBC1921 = 0.30 (0.25, 0.35);
LBC1936 = 0.26 (0.24, 0.28); MICROS = 0.93 (0.87, 0.99); NFBC1966 = 1.02
(1.00, 1.04); NSPHS = 2.83 (2.64, 3.02); ORCADES = 0.81 (0.75, 0.87);
QIMR = 0.22 (0.21, 0.23); RS = 0.29 (0.28, 0.30); SOCCS = 0.30 (0.28, 0.32);
YFS = 0.81 (0.79, 0.83). (B) shows mean FROHLD by population sample.
FROHLD is defined as the percentage of the genotyped autosomal
genome in ROH measuring at least 1.0 Mb, derived from a panel of
independent SNPs. Mean values of FROHLD per population (with 95%
confidence intervals) are: CROATIA-Korcˇula = 0.67 (0.61, 0.73); CROATIA-
Split = 0.13 (0.11, 0.15); CROATIA-Vis = 0.48 (0.43, 0.53); EGCUT = 0.10
(0.09, 0.10); ERF = 0.53 (0.48, 0.58); FINRISK = 0.21 (0.20, 0.23);
HBCS = 0.13 (0.11, 0.14); H2000 = 0.23 (0.22, 0.24); INGI-CARL = 0.44
(0.34, 0.54); INGI-FVG = 0.93 (0.86, 0.99); INGI-VB = 0.41 (037, 0.45);
LBC1921 = 0.05 (0.02, 0.09); LBC1936 = 0.02 (0.01, 0.03); MICROS = 0.47
(0.43, 0.51); NFBC1966 = 0.32 (0.31, 0.33); NSPHS = 1.17 (1.07, 1.27);
ORCADES = 0.35 (0.31, 0.39); QIMR = 0.013 (0.011, 0.015); RS = 0.04 (0.01,
0.07); SOCCS = 0.03 (0.02, 0.04); YFS = 0.20 (0.19, 0.21). (C) shows mean
Fhom by population sample. Fhom is defined as the percentage of
genotyped autosomal SNPs that are homozygous. Mean values of Fhom
per population (with 95% confidence intervals) are: CROATIA-Kor-
cˇula = 65.47 (65.43, 65.51); CROATIA-Split = 65.28 (65.25, 65.31); CROA-
TIA-Vis = 65.61 (65.58, 65.64); EGCUT = 65.69 (65.68, 65.70); ERF = 65.32
(65.29, 65.35); FINRISK = 65.25 (65.23, 65.27); HBCS = 65.13 (65.12, 65.14);
H2000 = 65.24 (65.23, 65.25); INGI-CARL = 65.20 (65.14, 65.26); INGI-
FVG = 65.53 (65.49, 65.57); INGI-VB = 65.18 (65.16, 65.20);
LBC1921 = 65.00 (64.97, 65.03); LBC1936 = 65.00 (64.99, 65.01); MI-
CROS = 65.26 (65.23, 65.29); NFBC1966 = 65.27 (65.26, 65.28);
NSPHS = 66.09 (66.01, 66.17); ORCADES = 65.37 (65.34, 65.40);
QIMR = 64.75 (64.74, 64.76); RS = 65.00 (64.99, 65.01); SOCCS = 64.97
(64.95, 64.99); YFS = 65.26 (65.25, 65.27).
doi:10.1371/journal.pgen.1002655.g001
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Although these results were highly significant, there was also a
high degree of heterogeneity across population samples. Some
further analyses were performed to explore the source of this
heterogeneity. Three of the twenty-one study samples (Carlantino
[INGI-CARL], Lothian Birth Cohort 1936 [LBC1936] and Val
Borbera [INGI-VB]) consistently showed a (non-significant)
positive association between genome-wide homozygosity and
height. In the LBC1936 and INGI-VB cohorts, the parameter
estimate was positive for all three measures. In INGI-CARL, the
parameter estimate was positive for FROH and FROHLD; however,
the maximum likelihood method used to find the parameter
estimate failed to converge for the Fhom analysis. Excluding these
three cohorts from the FROHLD meta-analysis reduced heteroge-
neity considerably, whilst not eliminating it completely (p-value for
heterogeneity = 0.01).
Removing these cohorts only slightly reduced heterogeneity in
the Fhom (p-value for heterogeneity = 6.6610
216) and FROH meta-
analyses (p-value for heterogeneity = 1.3610216). For both these
measures, other outliers also contributed to the heterogeneity. In
the case of FROH the Rotterdam Study (RS) showed a non-
significant positive association with height. Four additional cohorts
showed a non-significant positive association between Fhom and
height (EGCUT, CROATIA-Korcˇula, Queensland Institute of
Medical Research [QIMR] and RS).
To summarise, these results provide evidence of a highly
significant inverse association between genome-wide homozygosity
and height, regardless of which homozygosity estimate was used.
The weakest result was for FROH. The effect estimate for this
analysis was lower than those for the other 2 homozygosity
measures. The most heterogeneous result was for Fhom. The Fhom
analysis was similar to FROHLD in terms of effect size and
significance; however, when FROH was included in the Fhom
model, although the association remained significant, the effect
size fell, the p-value increased and heterogeneity increased. This
suggests that the effect was being driven mainly by longer ROH
which are more effectively captured by FROHLD. It is important
not to overstate this, however: even after controlling for FROH,
there is a significant, although highly heterogeneous inverse
association between Fhom and height, which suggests that a signal
is also coming from homozygous genotypes that are not found in
the long ROH characteristic of parental relatedness (Table 2).
Furthermore, no correlation was observed between sample mean
FROHLD and effect size (r = 0.03). Correlation between these two
measures would be expected if the observed effect was entirely
attributable to parental relatedness of recent origin. Nevertheless,
the most significant and least heterogeneous result was seen with
FROHLD. Furthermore, a moderate negative correlation was
observed between average FROHLD and the standard error of
the effect estimate (r =20.4), suggesting that the higher the level of
parental relatedness present in the sample, the greater the
precision of the effect estimate. This is because mean FROHLD is
related to its standard deviation (higher mean, higher variance)
and it is the variance in FROHLD that determines the standard
error of the estimate of the regression coefficient (i.e. higher
variance, lower standard error). For these reasons, it was decided
to use FROHLD in further analyses to explore possible confounding
factors.
All analyses were adjusted for age but, because the mean age of
most of the population samples in this study was over 50 years at
the time of genotyping, it was important to undertake additional
checks to ensure that the observed effect was not confounded by
the effects of osteoporotic, age-related shrinking. We used the
Northern Finland Birth Cohort 1966 (NFBC1966), where all
subjects were under 40 at the time of measurement. In this cohort,
there was a significant inverse association (p= 0.002) between
FROHLD and height, with a 1% increase in FROHLD associated
with a decrease of 0.13 in the z-score for height (95% confidence
interval 20.16, 20.10). This is equivalent to a reduction in height
of 5.3 cm (95% confidence interval 24.1, 26.6) in the offspring of
first cousins compared with the offspring of unrelated parents, a
stronger effect than observed in the meta-analysis of the full
sample. We also repeated the FROHLD analysis for a subset of
individuals aged under 40 years of age (15 cohorts, n = 9909) and
the relationship remained significant, although the effect size was
much smaller (1% increase in FROHLD associated with a decrease
of 0.009 in the z-score for height (95% confidence interval20.013,
20.0049; p = 2.1561025). This is equivalent to a reduction in
height of 0.4 cm (95% confidence interval 20.2, 20.5) in the
offspring of first cousins compared with the offspring of unrelated
parents.
The final stage in this analysis was to investigate possible
confounding by socio-economic status (SES) of the observed
association between genome-wide homozygosity and reduced
height. Four of the 21 cohorts (Erasmus Rucphen Family Study
[ERF], MICROS, NSPHS and QIMR) did not collect data on
SES and so were excluded from further analyses. SOCCS
estimated SES using a composite measure of deprivation based
on residential address; however, because this was an area- rather
than an individual-level estimate and because only one other
cohort (ORCADES) used this measure, SOCCS was also excluded
from analyses of SES. Eleven cohorts recorded an ordinal measure
of educational attainment (CROATIA-Korcˇula, CROATIA-Split,
CROATIA-Vis, EGCUT, the National FINRISK Study [FIN-
RISK], the Health2000 Survey [H2000], FVG-Genetic Park
[INGI-FVG], INGI-VB, NFBC1966, ORCADES and RS). Seven
cohorts provided an ordinal measure of occupational status
(EGCUT, Helsinki Birth Cohort Study [HBCS], INGI-CARL,
INGI-FVG, INGI-VB, the Lothian Birth Cohort 1921
[LBC1921], LBC1936 and the Young Finns Study [YFS]);
however, the maximum likelihood method used to find the
parameter estimate failed to converge for INGI-FVG so this
cohort was excluded from the occupational status analysis. We
Table 2. Meta-analysis of the association between height and genome-wide homozygosity, adjusted for age and sex only.
Homozygosity
measure
Number of
participants
Effect size
(z-score units)
95% Confidence
Interval p-value
p-value
(heterogeneity)
FROH 35,808 20.012 20.015, 20.008 1.23610
211 4.7610216
FROHLD 35,808 20.065 20.071, 20.058 1.40610
288 3.761027
Fhom 35,378 20.11 20.12, 20.10 1.10610
283 8.7610219
Fhom adj FROH 35,378 20.023 20.030, 20.016 5.36610
211 1.56102124
doi:10.1371/journal.pgen.1002655.t002
Inbreeding Depression on Height
PLoS Genetics | www.plosgenetics.org 6 July 2012 | Volume 8 | Issue 7 | e1002655
conducted four meta-analyses to investigate whether educational
attainment or occupational status confounded the association
between genome-wide homozygosity (as measured by FROHLD)
and height. First, we analysed the eleven cohorts with educational
attainment data available. Two meta-analyses were performed,
one adjusting for age, sex, genomic kinship and FROHLD only and
one adjusting for age, sex, genomic kinship, FROHLD and
educational attainment. Results were then compared to assess
possible confounding by educational attainment. This process was
then repeated for the seven cohorts with data available on
occupational status. Results are summarised in Table 3. A forest
plot illustrating the results of the educational attainment meta-
analyses is shown in Figure 3.
Inclusion of educational attainment in the model made very
little difference to the size, direction and significance of the effect.
If anything, inclusion of educational attainment strengthened the
association between reduced height and FROHLD, although
heterogeneity was also increased. Inclusion of occupational status
in the model also made very little difference: in the meta-analysis
of the seven cohorts with data on occupational status, no
significant association between reduced height and FROHLD was
observed, either with or without the inclusion of occupational
status in the model.
Discussion
This study found evidence for a strongly significant inverse
association between genome-wide homozygosity and height (i.e.
inbreeding depression) using three alternative estimates of genomic
homozygosity, with each method capturing a somewhat different
aspect of this phenomenon. Whereas all three measures are
strongly correlated, there are also important differences, particu-
larly between Fhom and both FROH measures. For example,
whereas the Estonian sample (EGCUT) had the second highest
mean value for Fhom, it had one of the lowest mean values for
FROHLD. There are several possible explanations for this. Firstly, it
may be suggestive of a small, isolated population deep in the past
but with a larger population size and low levels of parental
relatedness in recent generations. Secondly, ascertainment bias in
the selection of SNPs may also influence these patterns, as markers
present in the HumanHap300 panel are more likely to be
heterozygous in NW Europeans [37]. Thirdly, it may be that the
level of parental relatedness in the sample is lower than that in the
population.
The strongest association between genome-wide homozygosity
and reduced height was observed using FROHLD, a measure which
estimates homozygosity attributable to recent parental relatedness.
There is, however, an important caveat: a significant association
was also observed between reduced height and Fhom, controlled for
FROHLD, suggesting that homozygous genotypes not located in the
long ROH characteristic of recent parental relatedness are also
important. We estimated that the increased genome-wide homo-
zygosity that is characteristic of consanguinity results in a
reduction of up to 3 cm in the height of the offspring of first
cousins compared with the offspring of unrelated parents. Using
FROHLD, we then expanded the model to explore possible
confounding factors. Firstly, we investigated the possible con-
founding effects of age-related shrinking. Adult height is the
combined effect of growth during childhood and adolescence and
loss of height during ageing [11]. There is a powerful age-cohort
effect on homozygosity [38] (McQuillan and Wilson unpublished):
the rapid pace of urbanisation and population mobility that we
have witnessed over the past century has resulted in an observable
decrease in homozygosity in younger, compared with older age
cohorts. Reduced height is also associated with age, both as a
cohort effect reflecting improvements in nutrition and living
standards, and because as part of the natural process of ageing,
adults lose height as they age due to osteoporotic changes. This
process, which is particularly marked in women, may start as
young as age 40 [39], with the effects accelerating with age [40].
All analyses were adjusted for age, but as an additional test, we
restricted the samples to individuals aged ,40. The NFBC1966
sample set provided a further check, as all subjects were aged 31
years at the time of measurement. The inverse association between
FROHLD and height remained in both these analyses, suggesting
that confounding as a result of the osteoporotic effects of ageing
was not a major factor in these samples. The NFBC1966 analysis
also suggests that the relationship between genome-wide homo-
zygosity and height is not confounded by the simultaneous
Figure 2. Forest plot of the effect of FROHLD on height. Results of
a meta-analysis of the association between FROHLD and height are
shown for twenty-one population samples. The model was adjusted for
age and sex in all samples. Additionally, it was adjusted for genomic
kinship in samples with pairs of related individuals (CROATIA-Korcˇula,
CROATIA-Split, CROATIA-Vis, ERF, FINRISK, HBCS, H2000, INGI-CARL,
INGI-FVG, INGI-VB, MICROS, NFBC1966, NSPHS, ORCADES and YFS). The
plot shows estimated effect sizes (solid squares) for each population,
with 95% confidence intervals (horizontal lines). Each sample estimate is
weighted by the inverse of the squared standard error of the regression
coefficient, so that the smaller the standard error of the study, the
greater the contribution it makes to the pooled regression coefficient.
The area of the solid squares is proportional to the weighting given to
each study in the meta-analysis. Effect sizes in z-score units (with 95%
confidence intervals) are: CROATIA-Korcˇula =20.02 (20.09, 0.04);
CROATIA-Split =20.06 (20.1, 20.002); CROATIA-Vis =20.07 (20.1,
20.01); EGCUT =20.09 (20.04, 0.2); ERF =20.08 (20.1, 20.05);
FINRISK =20.1 (20.2, 20.07); HBCS =20.04 (20.2, 0.1); H2000 =20.2
(20.5, 0.04); INGI-CARL = 0.02 (20.03, 0.07); INGI-FVG =20.0001 (20.08,
0.08); INGI-VB = 0.005 (20.03, 0.04); LBC1921 =20.1 (20.3, 0.04);
LBC1936 = 0.2 (20.1, 0.4); MICROS = 20.06 (20.08, 20.05);
NFBC1966 =20.1 (20.2, 20.1); NSPHS =20.07 (20.07, 20.06); OR-
CADES =20.04 (20.08, 0.001); QIMR =20.07 (20.5, 0.3); RS =20.02
(20.1, 0.08); SOCCS =20.05 (20.4, 0.3); YFS =20.3 (21.2, 0.7).
doi:10.1371/journal.pgen.1002655.g002
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improvements in nutrition and living standards over the last
century.
Secondly, we assessed possible confounding by socio-economic
status. The association between low childhood SES and reduced
adult stature is well established, with the likely mechanism being
poor nutrition during childhood [6], although shared genetic
factors cannot be excluded. There is no direct evidence on the
association between genome-wide homozygosity and SES;
however there is a substantial literature on the association
between consanguinity, or kin marriage, and SES, albeit not in
European populations, where kin marriage is rare. In South and
West Asian Muslim populations, where kin marriage is custom-
ary, many studies have reported an inverse association between
consanguinity and women’s educational status [41], although the
picture is less clear-cut in men [42]. In a large post-World War
Two study of the children of consanguineous parents living in the
Japanese cities of Hiroshima and Nagasaki, which used a multi-
dimensional SES score, Schull and Neel found a small negative
correlation between consanguinity and SES [43]. A later Japanese
study also found evidence of confounding by SES, although the
direction of the effect was opposite depending on the urban or rural
background of the subjects [33]. SES can be estimated in a variety of
different ways: the measures available to us here were educational
attainment and occupational status. We grouped all the cohorts with
ordinal measures of educational attainment together and performed
two meta-analyses: one adjusting for age, sex and genomic kinship
only and the other adjusting for age, sex, genomic kinship and
educational attainment. We compared the two meta-analyses to
assess the effect of educational attainment as a possible confounder.
We repeated this process for the cohorts with ordinal measures of
occupational status. The inclusion of either SES measure in the
model made very little difference to the results. We therefore found
no strong evidence for confounding by SES, although the limited
data available on SES mean that confounding by SES cannot be
ruled out entirely.
While we did not have access to raw intensity data with which to
call hemizygous deletions, which can masquerade as ROH, two
different studies give us confidence that such copy number
variation will only have a very minor effect on our results. First, in
the ORCADES population, removing ROH which overlapped
with deletions resulted in only a 0.3% reduction in the sum length
of ROH across the cohort [36]. Second, the median length of
these deletions was ,10 kb in a dataset of .7,000 European-
heritage subjects, whereas the median length of ROH in the same
studies was ,2000 kb, showing that the vast majority of deletions
will be smaller than the ROH under study here [44]. However, we
note that an increased burden of deletions has recently been
associated with short stature [45].
Our results are consistent with those of Macgregor and
colleagues, who found a significant inverse association between
height and both the inbreeding coefficient derived from genea-
logical data (Fped) (p = 0.03; n = 60) and genome-wide homozy-
gosity (p = 0.02; n = 593) in the extreme isolate population of
Norfolk Island [34]. The probable reason that they were able to
see an effect with such small samples is that they observed much
higher levels of parental relatedness than are present in most of the
samples used in the present study, therefore the study had greater
power to detect an effect. Over one quarter (26%) of their total
sample had Fped.0, with mean Fped = 0.044. This contrasts with,
for example, only 10% of the ORCADES sample having Fped.0,
with mean Fped = 0.01 using pedigrees of a similar depth
(unpublished data). Although comparable pedigree data are not
available for all samples, it is probable that, with the possible
exception of NSPHS, all the samples in the present study have
lower levels of Fped and genome-wide homozygosity and thus
lower power to detect an association with height than is the case in
the Norfolk Island sample of descendants of the Bounty mutineers.
Cultural attitudes to consanguinity are at best ambivalent in
Europe, so marriage between first cousins is rare, even in the nine
isolated population samples in our consortium, where inflated
levels of parental relatedness are predicted simply as a function of
population size and endogamy.
The present study’s analyses provide strong evidence for an
association between genomic homozygosity and reduced height;
however, there is also strong evidence of heterogeneity. Although
we did not find a significant positive association between FROHLD
and height in any sample, there was a small number of non-
significant positive associations and overall there was considerable
variation in the magnitude of the observed effects among
population samples. One possible explanation for this is that the
observed effects are found only in individuals whose parents are
closely related (e.g. as first cousins). If this were the case, however,
the strongest effects would be observed in the samples with the
highest levels of parental relatedness. In fact, we found no
correlation between mean sample FROHLD and effect size. We also
found evidence of an association after controlling for parental
relatedness, suggesting that homozygous genotypes not resulting
from recent parental relatedness also contribute to the observed
association. The data do not, then, support the hypothesis that the
more inbreeding there is in the sample, the stronger the observed
effect. We did, however, find a moderate negative correlation
between the mean sample FROHLD and the SE of the FROHLD
effect estimate, which suggests that the more inbreeding there is in
the sample the greater the power to detect an effect and therefore
the more precise the estimate of the effect.
One puzzling result of this study was the discrepancy in the
results of the meta-analyses of FROH and FROHLD. The difference
in ROH length threshold may contribute to this discrepancy. The
1.5 Mb threshold for FROH was chosen on the basis of an
empirical analysis of several European-heritage populations [36].
Table 3. Meta-analysis assessing potential confounding of SES variables on the association between FROHLD and height.
Covariates N samples N subjects Effect size
95% Confidence
Interval p-value
p-value
(heterogeneity)
Age, sex, FROHLD 11 22,430 20.067 20.083, 20.051 6.3610
217 1.961027
Age, sex, FROHLD, EA 11 22,085 20.068 20.082, 20.053 5.2610
220 4.961029
Age, sex, FROHLD 7 10,161 0.0060 20.020, 0.032 0.65 0.55
Age, sex, FROHLD, OS 7 8,459 20.0063 20.037, 0.024 0.69 0.073
SES variables are educational attainment (EA) and occupational status (OS).
doi:10.1371/journal.pgen.1002655.t003
Inbreeding Depression on Height
PLoS Genetics | www.plosgenetics.org 8 July 2012 | Volume 8 | Issue 7 | e1002655
All individuals in all samples observed in this study, which also
used the Illumina Hap300 SNP array, had ROH,1.5 Mb. ROH
longer than this were more common in the offspring of related
parents, although still present in most offspring of unrelated
parents. With the benefit of hindsight, a longer and thus more
stringent ROH length threshold may have been preferable, in
terms of differentiating ROH resulting from close parental
relatedness originating in recent generations from what might be
termed population homogeneity resulting from population isola-
tion deeper in the past. In contrast, the FROHLD measure does not
detect ROH arising from common ancient haplotypes in the
population because SNPs in LD are removed before the analysis.
Any ROH detected using FROHLD are the result of parental
relatedness of recent origin. For FROHLD the aim is to maximise
the ROH that can be detected by setting a minimum length
threshold which is as low as possible. ROH are identified by
observing a string of contiguous homozygous genotypes. The
greater the number of contiguous homozygous genotypes, the
stronger the probability that what is observed is a true ROH (i.e. a
segment where the entire stretch of unobserved intervening DNA
is also homozygous), rather than just a chance observation.
Because of the reduced number of SNPs, and thus reduced SNP
density, in the LD-pruned SNP panels used for the FROHLD
analysis, detection of ROH shorter than 1 Mb becomes unreliable:
hence 1 Mb was used as the threshold.
The purpose of carrying out this analysis was to investigate
possible genome-wide recessive effects on height. These results
are important because by showing an association with genome-
wide homozygosity rather than specific individual SNPs, we
provide evidence that there is a polygenic recessive component
to the genetic architecture of height: i.e. that the observed
reductions in height associated with genome-wide homozygosity
result from the combined effects of many recessive alleles of
individually small effect size, located across the genome. The
proportion of the phenotypic variance explained by FROHLD
was very variable across cohorts, but the average was 0.4%.
Secondly, by demonstrating that the strongest signal comes from
the long ROH characteristic of parental relatedness, we provide
evidence that the observed effect is primarily the result of rare,
rather than common, recessive alleles. Short ROH (measuring
up to 2 Mb) are a common feature of all our genomes [36] and
their locations are remarkably consistent across different
populations, at least within Europe [46]. In contrast, the longer
ROH characteristic of parental relatedness are randomly
distributed across the genome [36], can be composed of
common or rare haplotypes, and as such are predicted to be
enriched for rare recessive variants. Our suggestion that it is
rare, rather than common, recessive variants that are driving the
observed effect is consistent both with theoretical expectations
[47] and with empirical data. Two recent studies found evidence
that functional regions of the genome (i.e. protein coding
regions or regions governing gene expression) are enriched for
rare genetic variants. Zhu et al. (2011) conclude that rare, at
least moderately harmful, variants constitute the majority of
Figure 3. Forest plot of the effect of FROHLD on height, adjusted
for educational attainment. Results of a meta-analysis of the
association between FROHLD and height are shown for the eleven
population samples which collected data on educational attainment.
(A) shows the model adjusted for age, sex and educational attainment
in all samples and additionally for genomic kinship in samples with pairs
of related individuals (CROATIA-Korcˇula, CROATIA-Split, CROATIA-Vis,
FINRISK, H2000, INGI-FVG, INGI-VB NFBC1966 and ORCADES). Effect
sizes in z-score units (with 95% confidence intervals) are: CROATIA-
Korcˇula =20.02 (20.07, 0.04); CROATIA-Split =20.05 (20.08, 20.01);
CROATIA-Vis =20.06 (20.1, 0.02); EGCUT =20.08 (20.5, 0.4); FIN-
RISK =20.1 (20.2, 20.03); H2000 =20.2 (20.8, 0.4); INGI-FVG = 0.1
(21.0, 1.2); INGI-VB = 0.009 (20.02, 0.04); NFBC1966 =20.1 (20.2, 20.1);
ORCADES =20.06 (20.1, 20.007); RS =20.02 (20.1, 0.08). (B) shows the
model adjusted for age and sex in all samples and additionally for
genomic kinship in samples with pairs of related individuals (CROATIA-
Korcˇula, CROATIA-Split, CROATIA-Vis, FINRISK, H2000, INGI-FVG, INGI-VB,
NFBC1966 and ORCADES). Effect sizes and 95% confidence intervals are
as in Figure 2. The plots show estimated effect sizes (solid squares) for
each population, with 95% confidence intervals (horizontal lines). Each
sample estimate is weighted by the inverse of the squared standard
error of the regression coefficient, so that the smaller the standard error
of the study, the greater the contribution it makes to the pooled
regression coefficient. The area of the solid squares is proportional to
the weighting given to each study in the meta-analysis.
doi:10.1371/journal.pgen.1002655.g003
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human functional variation [48]. Li et al. (2010) found that non-
synonymous coding SNPs were much rarer than synonymous
coding SNPs, suggesting that these SNPs have been subject to
purifying selection, which in turn suggests that they are
deleterious. They found that this pattern was stronger in the
X-chromosome than in the autosomes, suggesting that most rare
deleterious SNPs are recessive [49].
These findings are also important because, if there is a
polygenic, rare, recessive component to the genetic architecture
of height, this might also be the case for disease-associated QT of
biomedical importance, such as blood pressure and lipid levels.
Indeed this is more likely, if these traits are associated with fitness.
A high dominance variance has been reported in systolic blood
pressure (SBP) and LDL cholesterol in the Hutterites [50]. For
this reason, there is a theoretical expectation that these QT will
be influenced by genome-wide homozygosity. There have been
many empirical studies over the years which have explored this
recessive component to the genetic architecture of blood pressure
and LDL cholesterol; however until genome-wide scan data
became routinely affordable, this could only be investigated
indirectly using inbreeding coefficients derived from genealogical
data (Fped). Such measures are highly error-prone and cannot
account for stochastic variation in the inheritance process.
Nevertheless, various studies have found evidence of a significant
positive association between blood pressure and Fped
[51,52,53,54,55] although other similar studies found no such
evidence [56,57]. One small study by Campbell and colleagues
replicated these findings using a genomic measure of homozy-
gosity derived from microsatellite data [32]. Blood pressure in this
Croatian island isolate population was significantly (p,0.05)
higher in the offspring of consanguineous parents compared with
the offspring of unrelated parents. Similarly, there is some
evidence of a positive association between total cholesterol and
Fped [58] and between low density lipoprotein cholesterol (LDL)
and Fped [59] and of a negative association between high density
lipoprotein (HDL) and Fped [60], although other studies have
come up with more ambiguous results [28,55]. The study by
Campbell and colleagues found significant positive associations
between both total cholesterol and LDL cholesterol and
homozygosity, using a panel of microsatellite markers. All these,
however, were very small studies. The ROHgen consortium is
well placed to investigate these questions thoroughly: we have
access to large numbers of subjects; we can replicate investiga-
tions in a diverse range of European-heritage populations and we
have developed a robust methodology applicable to any number
of different QT.
Materials and Methods
Ethics Statement
Each study had ethical approval for genetic research into the
basis of complex traits, approved by the appropriate committees in
each country. All participants provided written informed consent.
As analyses were performed locally by cohort analysts, no data
were shared across national boundaries.
Study Participants
This meta-analysis combined data from 21 European or
European-heritage population samples: The Estonian Genome
Centre University of Tartu (EGCUT), the Erasmus Rucphen
Family Study (ERF), the National FINRISK Study (FINRISK)
(genotyped samples from 1997, 2002 and 2007 study years), the
Health 2000 Survey (H2000), the Helsinki Birth Cohort (HBCS),
the Lothian Birth Cohort 1921 (LBC1921), the Lothian Birth
Cohort 1936 (LBC1936) the Carlantino Project (INGI-CARL),
Friuli-Venezia-Giulia-Genetic Park (INGI-FVG), Korcˇula
(CROATIA-Korcˇula), Micro-Isolates in South Tyrol (MICROS),
the Northern Finland 1966 Birth Cohort (NFBC1966), the
Northern Sweden Population Health Study (NSPHS), the Orkney
Complex Disease Study (ORCADES), Queensland Institute of
Medical Research (QIMR), the Rotterdam Study (RS), the Study
of Colorectal Cancer in Scotland (SOCCS), Split (CROATIA-
Split), Val Borbera (INGI-VB), Vis (CROATIA-Vis) and the
Young Finns Study (YFS). Most (n = 16) were population-based
samples, 4 were birth cohorts and 1 was a case-control sample.
Five study populations were Finnish, 4 were Scottish, 4 were
Italian, 3 were Croatian, 2 were Dutch, 1 was Estonian, 1 was
Swedish and 1 was Australian of NW European heritage. Most of
the samples were drawn from genetically isolated populations or
populations with increased homozygosity, such as the Finns. The
total number of participants was 35,808. All studies were carried
out after the appropriate local ethical approval had been obtained.
All participants provided written informed consent. Full sample
details are given in Table S1.
Measurement of Height
In all studies apart from SOCCS, height was measured by
trained personnel using a stadiometer. SOCCS participants
provided self-reported measurements of height. This was validated
by measuring height in a subset of the sample by trained personnel
using a stadiometer. There was a high concordance between the
two measures.
Genotyping
All genotyping was performed on the Illumina platform but
using four different SNP panels. Seven samples were genotyped
using the Illumina HumanHap 300 panel, six using the Illumina
HumanHap 370 Duo/Quad panels, five using the Illumina
Human 610 Quad panel, one using the Illumina Human 670
Quad panel and one using both the 370 and 610 panels. In order
to harmonise the data across samples, SNPs present in the
HumanHap 300 panel were extracted and the analysis was
conducted using these SNPs only. Quality control procedures were
performed on each sample separately, with the minimum
requirements as follows. Individuals with more than 5% missing
genotypes were excluded. SNPs missing in more than 10% of
samples were excluded, as were SNPs failing the Hardy-Weinberg
equilibrium test at p,0.0001 and SNPs with minor allele
frequency (MAF),0.01.
Measures of Genome-Wide Homozygosity
These were detected using the Runs of homozygosity routine in
plink [61,62]. This slides a moving window of 5000 kb (minimum
50 SNPs) across the genome to detect long contiguous runs of
homozygous genotypes. An occasional genotyping error occurring
in an otherwise unbroken homozygous segment could result in the
underestimation of ROH lengths. To address this, the routine
allows one heterozygous and five missing calls per window.
FROH. ROH were defined as runs of at least 25 consecutive
homozygous SNPs spanning at least 1500 kb, with less than a
100 kb gap between adjacent SNPs and a density of SNP coverage
within the ROH of no more than 20 kb/SNP. For each
individual, an F statistic termed FROH [36] was derived by
summing the lengths of all ROH longer than 1500 kb and
expressing this as a percentage of the typed autosomal genome (i.e.
the sum of the length of all the autosomes from the first to the last
SNP, excluding the centromeres). 1500 kb was chosen as the
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minimum length of ROH because observational studies in
European populations have shown that whereas all individuals
have ROH shorter than 1500 kb, ROH longer than this are more
likely to be the result of parental relatedness [36]. We have shown
previously that this measure is strongly correlated (r = 0.86) with
pedigree-derived inbreeding coefficients [36].
FROHLD. An alternative approach to deriving an inbreeding
coefficient from ROH is to start by pruning the SNP panel of
SNPs in strong linkage disequilibrium (LD), in order to remove
ROH that are very common due to the high frequency of ancestral
haplotypes. SNP panels were pruned using the pairwise option in
plink [61]. At each point, it calculates LD between each pair of
SNPs in a window of 50 SNPs and removes one of each pair if LD
exceeds the user-defined limit (set here at r2 = 0.1). ROH
parameters were adjusted to reflect the reduced number of SNPs.
The minimum number of consecutive homozygous SNPs consti-
tuting a ROH was set at 12 (probability of occurring by chance
p,0.005 in all samples). The minimum length of ROH was set at
1000 kb, with no more than 250 kb gap between adjacent SNPs
and a density of SNP coverage within the ROH of no more than
100 kb/SNP. Individual FROHLD statistics were then calculated as
described above. This approach yields a more stringent estimate of
parental relatedness, as it removes all ROH that are there simply
because of parental sharing of long haplotypes that are common in
the population. ROH consisting of independent SNPs will be of
recent origin and will thus be enriched for rarer haplotypes. Again,
this is highly correlated with the pedigree-derived inbreeding
coefficient (r = 0.82 in a subset of 241 subjects from the
ORCADES sample with complete pedigree information available
to five ancestral generations).
Observed homozygosity (Fhom). This is defined as the
number of observed homozygous genotypes per individual,
expressed as a percentage of the number of non-missing genotypes
for that individual. This measure is less strongly correlated with
pedigree inbreeding coefficients than the above (r = 0.76 [36]), as it
counts all homozygous genotypes and not simply those found in
long ROH arising from recent pedigree loops.
Statistical Analysis
All tests were two sided and a p-value threshold of 0.05 was
used. In order to account for differences in mean height among
population samples, all height measures are expressed as z-scores.
Because genetically isolated populations are characterised by high
levels of relatedness between individuals, measures of height are
not independent and therefore conventional regression techniques
are not appropriate. The CROATIA-Korcˇula, CROATIA-Split,
CROATIA-Vis, ERF, FINRISK, HBCS, H2000, INGI-CARL,
INGI-FVG, INGI-VB MICROS, NFBC1966, NSPHS, OR-
CADES and YFS samples were therefore analysed using a linear
mixed polygenic model in GenABEL. This programme maximises
the likelihood of the data under the polygenic model with specified
covariates. It reports twice the negative maximum likelihood
estimates and the inverse of the variance-covariance matrix at the
point of maximum likelihood [63,64,65]. The z-score for height
was analysed with age, sex, genome-wide homozygosity measure
and either educational attainment or occupational status fitted as
fixed effects. This model also fits a genomic kinship matrix, which
estimates pairwise relatedness, derived on the basis of identical by
state (IBS) sharing, weighted by allele frequency, so that a pair of
individuals sharing a rare allele is estimated to be more closely
related than a pair sharing a common allele. All other samples
consist of unrelated individuals, so data were analysed in SPSS using
simple linear regression, with age, sex, genome-wide homozygosity
measure and either educational attainment or occupational status as
covariates. Before embarking on analysis of the SOCCS data, the
sample was analysed using binary logistic regression to check that
height is not associated with colorectal cancer status. There was no
association between height and colorectal cancer, so cases and
controls were analysed as a single sample.
Meta-Analysis
Results were combined in a meta-analysis using the inverse
variance method to combine effect size estimates from each
sample [63]. This weights each sample estimate by the inverse of
the squared standard error of the regression coefficient, so that the
smaller the standard error of the study, the greater the
contribution it makes to the pooled regression coefficient.
Estimation of the Reduction in Height Resulting from
Increased Homozygosity in the Offspring of First Cousins
Compared with the Offspring of Unrelated Individuals
In order to standardise across the different population samples
in this study, we converted height measurements into z-scores. The
results of each meta-analysis report a pooled estimate of the
change in this z-score associated with a 1% increase in genomic
homozygosity. In order to make this easier to interpret, we express
this in the text as the difference in height between the offspring of
first cousins and the offspring of unrelated parents. The first step in
this analysis was to estimate the difference in observed genomic
homozygosity between the offspring of first cousins and the
offspring of unrelated parents (a more realistic approach than
using the theoretical predictions of Fped = 0.0625 and 0). For each
measure of genomic homozygosity we estimated this difference
separately in 3 different populations where genealogical and
genomic data were available for the reliable identification of the
offspring of first cousins. In each population group and for each
measure of genomic homozygosity, we estimated the mean
difference between the offspring of first cousins and the offspring
of unrelated parents. We multiplied this by the effect size estimate
from the regression meta-analysis to give a z-score estimate for the
reduction in height in the offspring of first cousins compared with
the offspring of unrelated individuals. To convert each of these z-
scores into cm, we then multiplied them by an estimate of the SD
for height across the whole sample, derived by taking the SD for
each sample in turn and weighting it by sample size. Two of the
three populations used for this analysis were part of the main study
(ORCADES and MICROS). The third was a small Irish sample,
consisting of members of both settled and traveller communities in
Ireland (unpublished data, JF Wilson and GL Cavalleri). We
repeated this analysis separately in these three populations, partly
because of the very small number of first cousin offspring in any
single sample in our study and partly to ensure that the observed
difference in homozygosity was not simply an artefact of one
particular population sample.
Supporting Information
Figure S1 Forest plot of the effect of FROH on height. Results of
a meta-analysis of the association between FROH and height are
shown for twenty-one population samples. The model was
adjusted for age and sex in all samples. Additionally, it was
adjusted for genomic kinship in samples with pairs of related
individuals (CROATIA-Korcˇula, CROATIA-Split, CROATIA-
Vis, ERF, FINRISK, HBCS, H2000, INGI-CARL, INGI-FVG,
INGI-VB, MICROS, NFBC1966, NSPHS, ORCADES and
YFS). The plot shows estimated effect sizes (solid squares) for
each population, with 95% confidence intervals (horizontal lines).
Each sample estimate is weighted by the inverse of the squared
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standard error of the regression coefficient, so that the smaller the
standard error of the study, the greater the contribution it makes to
the pooled regression coefficient. The area of the solid squares is
proportional to the weighting given to each study in the meta-
analysis. Effect sizes in z-score units (with 95% confidence
intervals) are: CROATIA-Korcˇula =20.03 (20.06, 20.003);
CROATIA-Split =20.005 (20.009, 20.00006); CROATIA-
Vis =20.03 (20.07, 0.007); EGCUT =20.04 (20.3, 0.2);
ERF =20.09 (20.9, 0.7); FINRISK =20.09 (20.2, 20.01);
HBCS =20.05 (20.2, 0.1); H2000 =20.16 (20.2, 20.1); INGI-
CARL = 0.01 (20.03, 0.05); INGI-FVG =20.03 (20.05,
20.005); INGI-VB = 0.001 (20.02, 0.02); LBC1921 =20.08
(20.2, 0.03); LBC1936 = 0.07 (20.1, 0.2); MICROS =20.05
(20.02, 20.008); NFBC1966 =20.08 (20.1, 20.05);
NSPHS =20.02 (20.04, 20.008); ORCADES =20.02 (20.06,
0.02); QIMR =20.06 (20.2, 0.09); RS = 0.003 (20.06, 0.06);
SOCCS =20.08 (20.2, 0.05); YFS =20.05 (20.1, 20.002).
(TIF)
Figure S2 Forest plot of the effect of Fhom on height. Results of a
meta-analysis of the association between Fhom and height are shown
for twenty population samples. For one sample (INGI-CARL) the
polygenic model failed to converge. The model was adjusted for age
and sex in all samples. Additionally, it was adjusted for genomic
kinship in samples with pairs of related individuals (CROATIA-
Korcˇula, CROATIA-Split, CROATIA-Vis, ERF, FINRISK,
HBCS, H2000, INGI-FVG, INGI-VB,MICROS, NFBC1966,
NSPHS, ORCADES and YFS). The plot shows estimated effect
sizes (solid squares) for each population, with 95% confidence
intervals (horizontal lines). Each sample estimate is weighted by the
inverse of the squared standard error of the regression coefficient, so
that the smaller the standard error of the study, the greater the
contribution it makes to the pooled regression coefficient. The area
of the solid squares is proportional to the weighting given to each
study in the meta-analysis. Effect sizes in z-score units (with 95%
confidence intervals) are: CROATIA-Korcˇula = 0.03 (20.03, 0.09);
CROATIA-Split =20.04 (20.09, 20.0009); CROATIA-
Vis =20.09 (20.26, 0.08); EGCUT = 0.002 (21.9, 1.9);
ERF =20.2 (20.3, 20.1); FINRISK =20.1 (20.2, 20.05);
HBCS =20.09 (20.4, 0.3); H2000 =20.2 (20.4, 0.03); INGI-
FVG =20.27 (20.33, 20.21); INGI-VB = 0.02 (20.04, 0.07);
LBC1921 =20.2 (20.5, 0.05); LBC1936 = 0.02 (20.2, 0.2);
MICROS =20.07 (20.1, 20.05); NFBC1966 =20.1 (20.3,
0.09); NSPHS =20.15 (20.16, 20.13); ORCADES =20.06
(20.1, 20.02); QIMR = 0.09 (20.05, 0.2); RS = 0.007 (20.07,
0.09); SOCCS =20.09 (20.3, 0.2); YFS =20.1 (20.2, 20.04).
(TIF)
Table S1 Details of genotyping, QC, data analysis and sample
characteristics by cohort.
(XLS)
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